Ansa Biotechnologies
Ansa Biotechnologies is building a faster and cheaper DNA synthesis service to accelerate synthetic biology research. Ansa's core technology is a novel DNA synthesis method based on enzymes that will be faster, cleaner and more accurate than existing methods. The unique approach, developed by the founders at UC Berkeley, uses an engineered template-independent polymerase conjugated to a single nucleoside triphosphate molecule to rapidly build a DNA sequence one base at a time.
Last updated on
About Ansa Biotechnologies
Founded
2018Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$83MCategory
Industry
Social ServicesLocation
City
EmeryvilleState
CaliforniaCountry
United StatesAnsa Biotechnologies
Find your buyer within Ansa Biotechnologies